Reports of heart inflammation in children and teens after receiving mRNA COVID vaccines have fueled further questions about vaccine safety. A pediatric cardiologist answers common questions about the risks of COVID vaccines versus COVID-19 infection.

Paralympian Sam Grewe shares his journey from being a young teen receiving a cancer diagnosis to becoming an athlete competing on a global stage, and how his diagnosis and experience inspired him to become a doctor.

Learn about CAR T-cell therapy, a state-of-the-art FDA approved leukemia gene therapy, which the University of Michigan C.S. Mott Children's Hospital offers.

How a new research initiative is empowering U-M physician-scientists to fight DIPG, one of the deadliest brain cancers, in innovative ways.

Just four percent of federal cancer research dollars go to pediatrics. But more research is needed to change the outcome for many childhood cancers.

Zane and Zach are 5 year old identical twins that were both diagnosed with Acute Lymphocytic Leukemia. Learn more about the twins and leukemia risk factors.

40+ C.S. Mott doctors collaborate at tumor board meetings on pediatric cancer treatment and cancer diagnoses. Learn more about this team approach to cancer care.

University of Michigan immunologist discusses using immunotherapy to treat pediatric brain cancer. Learn more about the cancer treatments being used for DIPG.

Gifts in memory of Chad Carr, grandson of former Michigan football coach Lloyd Carr, will help Michigan scientists to fight the deadly DIPG tumor Chad battled.

Pediatric neuroblastoma treatment has been revolutionized by combining immunotherapy & chemotherapy. Learn more about treating this devastating childhood disease.

New healthcare innovation from the University of Michigan Medical School could help children with brain cancer by limiting the creation of the ATRX protein.

Using DNA and RNA for Cancer Treatments |Michigan Health Lab